drugset / Trial / NCT03675841

Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media

NCT03675841 ↗

Phase 1 Unknown 33 enrolled Lee's Pharmaceutical Limited
RandomizedSequentialQuadruple-blindTreatment

Summary

Objective To observe the safety and tolerability of Pazufloxacin Mesylate Ear Drops of different concentrations in patients with simple chronic suppurative otitis media.

Timeline

Start
2018-07-29
Primary completion
2019-01-30
Completion
2019-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Pazufloxacin Mesilate Unknown 0.1 % Topical
Subject Pazufloxacin Mesilate Unknown 0.3 % Topical
Subject Pazufloxacin Mesilate Unknown 0.5 % Topical